Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) released a profit for its full year that Increases, from the same period last year
The company's earnings totaled RMB757.97 million, or RMB0.92 per share. This compares with RMB711.96 million, or RMB0.83 per share, last year.
Excluding items, Zhejiang Jingxin Pharmaceutical Co., Ltd. reported adjusted earnings of RMB712.08 million or RMB0.86 per share for the period.
The company's revenue for the period fell 2.1% to RMB4.069 billion from RMB4.158 billion last year.
Zhejiang Jingxin Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB757.97 Mln. vs. RMB711.96 Mln. last year.-EPS: RMB0.92 vs. RMB0.83 last year.-Revenue: RMB4.069 Bln vs. RMB4.158 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.